Identification of an Interleukin 17F/17A Heterodimer in Activated Human CD4+ T Cells
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
IL-17F and IL-17A are members of the IL-17 pro-inflammatory cytokine family. IL-17A has been implicated in the pathogenesis of autoimmune diseases. IL-17F is a disulfide-linked dimer that contains a cysteine-knot motif. We hypothesized that IL-17F and IL-17A could form a heterodimer due to their sequence homology and overlapping pattern of expression. We evaluated the structure of recombinant IL-17F and IL-17A proteins, as well as that of natural IL-17F and IL-17A derived from activated human CD4+ T cells, by enzyme-linked immunosorbent assay, immunoprecipitation followed by Western blotting, and mass spectrometry. We find that both IL-17F and IL-17A can form both homodimeric and heterodimeric proteins when expressed in a recombinant system, and that all forms of the recombinant proteins have in vitro functional activity. Furthermore, we find that in addition to the homodimers of IL-17F and IL-17A, activated human CD4+ T cells also produce the IL-17F/IL-17A heterodimer. These data suggest that the IL-17F/IL-17A heterodimer may contribute to the T cell-mediated immune responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A, -AF and -F trigger qualitatively similar signaling pathways, however IL-17A homodimers induce a far more potent signal compared to IL-17F homodimers, with IL-17AF thought to be intermediate signaling strength”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Wright et al., 2007
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00070-4 · Cited by 2,822
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
Cited by
Items 101–200 of 318
INTERLEUKIN-17 IN PULMONARY HOST DEFENSE
Aujla, S. J., Dubin, P. J., & Kolls, J. K. (2007) · Experimental Lung Research · doi:10.1080/01902140701756604 · Cited by 75
“It has recently been shown that IL17A and IL-17F can form heterodimers and the IL-17A=F heterodimer has activity greater than IL-17F homodimers and is nearly equal of that observed with IL-17A homodimers [32].”
BackgroundCurrent Concepts in Psoriatic Arthritis: Pathogenesis and Management
de Vlam, K., Gottlieb, A. B., & Mease, P. J. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1833 · Cited by 87
Current views on the functions of interleukin-17A-producing cells in atherosclerosis
Butcher, M. J., & Galkina, E. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0342 · Cited by 83
Frieder, J., Kivelevitch, D. N., Haugh, I. M., Watson, I., & Menter, A. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.893 · Cited by 80
Roles of IL-25 in Type 2 Inflammation and Autoimmune Pathogenesis
Deng, C., Peng, N., Tang, Y., Yu, N., Wang, C., Cai, X., Zhang, L., Hu, D., Ciccia, F., & Lu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691559 · Cited by 81
“IL-17A and IL-17F can form both homodimer and heterodimer, while IL-17B, IL-17C, IL-17D and IL-25 form homodimers to bind receptors (4, 5).”
BackgroundBrucklacher-Waldert, V., Steinbach, K., Lioznov, M. V., Kolster, M., Hölscher, C., & Tolosa, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901000 · Cited by 88
“A heterodimeric form of IL-17 comprising IL- 17A and IL-17F and its biological function has already been described ( 7 ).”
BackgroundInfluentialCarvalho, A. L., & Hedrich, C. M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.662047 · Cited by 81
Differentiation and function of pro-inflammatory Th17 cells
Dong, C. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.04.001 · Cited by 81
“We, as well as others, have shown that IL17 and IL-17F form a biologically active heterodimer with intermediate potency when compared with homodimers in inducing inflammatory genes [47,48].”
Expression of interleukin-17RC protein in normal human tissues
Ge, D., & You, Z. (2008) · International Archives of Medicine · doi:10.1186/1755-7682-1-19 · Cited by 72
“IL-17A/F heterodimer has also been reported [3,4].”
The role of IL17B-IL17RB signaling pathway in breast cancer
Alinejad, V., Dolati, S., Motallebnezhad, M., & Yousefi, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.120 · Cited by 77
The Interleukin-17 Family of Cytokines in Breast Cancer
Fabre, J., Giustiniani, J., Garbar, C., Merrouche, Y., Antonicelli, F. D., & Bensussan, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123880 · Cited by 81
“IL-17A, IL-17F and IL-17A/F dock to IL-17RA/RC, IL-17B and E involve IL-17RB subunit, IL-17C signals through IL-17RA/RE [50,51].”
BackgroundÖzçaka, Ö., Buduneli, N., Ceyhan, B. Ö., Akcalı, A., Hannah, V., Nile, C. J., & Lappin, D. F. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.120483 · Cited by 80
The role of IL-17 in psoriasis
Malakouti, M., Brown, G. E., Wang, E., Koo, J. Y. M., & Levin, E. C. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.879093 · Cited by 81
“Although the exact role IL-17F plays in the pathogenesis of psoriasis is unclear, it is found to induce the production of IL-6 in normal human epidermal keratinocytes, which is considered to be an objective measure of inflammation and is elevated in psoriasis lesions (30).”
BackgroundInfluentialHedrich, C. M., Rauen, T., Kis‐Tóth, K., Kyttaris, V. C., & Tsokos, G. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323261 · Cited by 71
IL-17RA Signaling in Airway Inflammation and Bronchial Hyperreactivity in Allergic Asthma
Willis, C. R., Siegel, L. A., Leith, A., Mohn, D., Escobar, S. M., Wannberg, S., Misura, K. M. S., Rickel, E., Rottman, J. B., Comeau, M. R., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0038oc · Cited by 73
The paradoxical role of IL-17 in atherosclerosis
Gong, F., Liu, Z., Liu, J., Zhou, P., Liu, Y., & Lü, X. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.05.007 · Cited by 71
Epigenetics, autoimmunity and hematologic malignancies: A comprehensive review
Ngalamika, O., Zhang, Y., Yin, H., Zhao, M., Gershwin, M. E., & Lu, Q. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.09.002 · Cited by 71
Fitzpatrick, L. R., Deml, L., Hofmann, C., Small, J. S., Groeppel, M., Hamm, S., Lemstra, S., Leban, J. J., & Ammendola, A. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21264 · Cited by 68
“IL-17 can exist as both an A/A homodimer and a F/A heterodimer during inflammation.(21,22) We found that TNBS administration caused large increases in IL-17 expression including homodimers and heterodimers (Fig.”
BackgroundPathophysiology of IL-33 and IL-17 in allergic disorders
Gupta, R. K., Gupta, K., & Dwivedi, P. D. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.09.005 · Cited by 68
Woś, I., & Tabarkiewicz, J. (2021) · Immunologic Research · doi:10.1007/s12026-021-09173-9 · Cited by 70
“IL-17F heterodimer that can activate fibroblasts and macrophages to produce IL-6 [51].”
BackgroundThe role of interleukin-17 in inflammation-related cancers
Zhang, X., Li, B., Lan, T., Chiari, C. C., Ye, X., Wang, K., & Chen, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1479505 · Cited by 89
Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis
Whibley, N., Tritto, E., Traggiai, E., Kolbinger, F., Moulin, P., Brees, D., Coleman, B. M., Mamo, A. J., Garg, A. V., Jaycox, J. R., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0915-428r · Cited by 65
“This receptor is also used by a heterodimer of IL-17A bound to IL-17F through a covalent disulfide linkage (IL-17AF) [30–34].”
BackgroundChandra, V., Li, L., Roux, O. L., Zhang, Y., Howell, R. M., Rupani, D. N., Baydogan, S., Miller, H. D., Riquelme, E. M., Petrosino, J. F., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.12.006 · Cited by 75
Mimpen, J. Y., Baldwin, M. J., Cribbs, A. P., Philpott, M., Carr, A. J., Dakin, S. G., & Snelling, S. J. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676173 · Cited by 69
“While these cytokines seem to induce qualitatively similar signals, IL-17A homodimer produces a much more potent signal than the IL-17F homodimer in human primary foreskin fibroblasts and mouse embryonic fibroblasts, with the IL-17AF heterodimer producing an intermediate signal (16, 30, 31).”
BackgroundIshiguro, A., Akiyama, T., Adachi, H., Inoue, J., & Nakamura, Y. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30108 · Cited by 70
Targeting IL-17 in autoimmunity and inflammation
Kim, B. S., Park, Y.-J., & Chung, Y. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0823-8 · Cited by 65
Tollenaere, M. A. X., Hebsgaard, J. B., Ewald, D. A., Lovato, P., Garcet, S., Li, X., Pilger, S., Tiirikainen, M. L., Bertelsen, M., Krueger, J. G., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20090 · Cited by 73
Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS
Bushnell, S. E., Zhao, Z., Stebbins, C. C., Cadavid, D., BUKO, A. M., Whalley, E. T., Davis, J. A., Versage, E. M., Richert, J. R., Axtell, R. C., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318259e123 · Cited by 69
Role of Interleukin-17F in Asthma
Kawaguchi, M., Kokubu, F., Fujita, J., Huang, S.-K., & Hizawa, N. (2009) · Inflammation & Allergy - Drug Targets · doi:10.2174/1871528110908050383 · Cited by 61
“Although IL-17F has been believed to form disulfide-bonded homodimers, recent reports have demonstrated that IL-17A and IL-17F also exist as heterodimers termed IL-17A/F [11].”
BackgroundEngineering of stable bispecific antibodies targeting IL-17A and IL-23
Mabry, R., Lewis, K. E., Moore, M. D., McKernan, P. A., Bukowski, T. R., Bontadelli, K., Brender, T., Okada, S. L., Lum, K. D., West, J. W., et al. (2009) · Protein Engineering Design and Selection · doi:10.1093/protein/gzp073 · Cited by 64
“Both molecules are found as homodimers (IL-17A/A and IL-17F/F) and as a heterodimer (IL-17A/F), all of which appear to mediate inflammatory responses associated with disease pathology (Fossiez et al., 1998; Wright et al., 2007).”
BackgroundThe biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
Gabay, C., & McInnes, I. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2680 · Cited by 71
“IL-17A and IL-17F are produced as homodimers primarily by activated CD4+ T cells (see Th17 cells below) and as IL-17A/IL-17F heterodimers with similar cysteins involved in the disulfide linkage as in homodimeric cytokines [91].”
BackgroundEffect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
Nirula, A., Nilsen, J., Klekotka, P. A., Kricorian, G., Erondu, N., Towne, J. E., Russell, C. B., Martin, D. A., & Budelsky, A. (2016) · Rheumatology · doi:10.1093/rheumatology/kew346 · Cited by 63
Saran, A., Nishizaki, D., Lippman, S. M., Kato, S., & Kurzrock, R. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.01.002 · Cited by 71
Th17-Associated Cytokines as a Therapeutic Target for Steroid-Insensitive Asthma
Morishima, Y., Ano, S., Ishii, Y., Ohtsuka, S., Matsuyama, M., Kawaguchi, M., & Hizawa, N. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/609395 · Cited by 61
“Since IL-17A and IL-17F can form homo- and heterodimers because of their sequence homology [37], they may have similar functions.”
BackgroundTamassia, N., Arruda-Silva, F., Calzetti, F., Lonardi, S., Gasperini, S., Gardiman, E., Bianchetto-Aguilera, F. M., Gatta, L. B., Girolomoni, G., Mantovani, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00795 · Cited by 63
“Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy? Arthritis Res Ther (2014) 16(4):426.”
BackgroundZhang, X., Yu, P., Wang, Y., Jiang, W., Shen, F.-C., Wang, Y., Tu, H., Yang, X., Shi, R., & Zhang, H. (2013) · Inflammation Research · doi:10.1007/s00011-013-0629-9 · Cited by 57
Dual inhibition of IL-17A and IL-17F in psoriatic disease
Iznardo, H., & Puig, L. (2021) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211037846 · Cited by 59
Oliver, R., Krueger, J. G., Glatt, S., Vajjah, P., Mistry, C., Page, M., Edwards, H., Garcet, S., Li, X., Dizier, B., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20827 · Cited by 54
Cytokine mediators of Th17 function
Spolski, R. J., & Leonard, W. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200839066 · Cited by 62
Interleukin-17A and -17F genes polymorphisms in lung cancer
Kaabachi, W., Amor, A. B., Kaabachi, S., Rafrafi, A., Tizaoui, K., & Hamzaoui, K. (2014) · Cytokine · doi:10.1016/j.cyto.2013.12.012 · Cited by 50
“IL-17F is discovered to share a strong homology to IL-17A, and they exist together as disulfide-linked homodimers or IL-17A/F heterodimers [33–35].”
BackgroundIL17A-Mediated Endothelial Breach Promotes Metastasis Formation
Kulig, P., Burkhard, S., Mikita-Geoffroy, J., Croxford, A. L., Hövelmeyer, N., Gyülvészi, G., Gorzelanny, C., Waisman, A., Borsig, L., & Becher, B. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0154 · Cited by 54
Regan, D. P., Aarnio, M., Davis, W. S., Carmichael, K. P., Vandenplas, M. L., Lauderdale, J. D., & Moore, P. A. (2011) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2011.00951.x · Cited by 54
Interleukin-17F Suppresses Hepatocarcinoma Cell Growth via Inhibition of Tumor Angiogenesis
Xie, Y., Sheng, W., Xiang, J., Ye, Z., & Yang, J. (2010) · Cancer Investigation · doi:10.3109/07357900903287030 · Cited by 51
“Moreover, IL-17F/IL-17A heterodimer has been shown to be expressed by Th17 cells (11, 12).”
BackgroundKurschus, F. C., & Moos, S. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.010 · Cited by 59
Interleukin-17 as a key player in neuroimmunometabolism
Douglas, A., Stevens, B., & Lynch, L. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00846-3 · Cited by 49
Potential Involvement of IL-17F in Asthma
Ota, K., Kawaguchi, M., Matsukura, S., Kurokawa, M., Kokubu, F., Fujita, J., Morishima, Y., Huang, S.-K., Ishii, Y., Satoh, H., et al. (2014) · Journal of Immunology Research · doi:10.1155/2014/602846 · Cited by 48
“Of note, recent reports have demonstrated that IL-17A and IL-17F can be produced as heterodimers termed IL-17A/F [11].”
BackgroundThe IL-17F/IL-17RC Axis Promotes Respiratory Allergy in the Proximal Airways
LUCA, A. D., Pariano, M., Cellini, B., Costantini, C., Villella, V. R., Jose, S. S., Palmieri, M., Borghi, M., Galosi, C., Paolicelli, G., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.063 · Cited by 51
Roles of Interleukin-17 in an Experimental Legionella pneumophila Pneumonia Model
Kimizuka, Y., Kimura, S., Saga, T., Ishii, M., Hasegawa, N., Betsuyaku, T., Iwakura, Y., Tateda, K., & Yamaguchi, K. (2011) · Infection and Immunity · doi:10.1128/iai.05544-11 · Cited by 50
The Th17/IL-17 Axis and Host Defense Against Fungal Infections
Tangye, S. G., & Puel, A. (2023) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2023.04.015 · Cited by 54
“IL-17A/IL-17F heterodimers have intermediate signaling strength 17–19 .”
Lonati, P. A., Brembilla, N. C., Montanari, E., Fontao, L., Gabrielli, A., Vettori, S., Valentini, G., Laffitte, E., Kaya, G., Meroni, P. L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105008 · Cited by 53
“Nonetheless, in our functional assays, IL-17F induced responses in fibroblasts similar to those induced by IL-17A, although higher concentrations were needed, in line with the reported lower potency of IL-17F compared to IL17A due to lower affinity for their common heterodimeric IL17RA/IL-17RC receptor [36].”
BackgroundThe Th17 Pathway in Vascular Inflammation: Culprit or Consort?
Robert, M., Miossec, P., & Hot, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888763 · Cited by 47
“IL-17A and IL-17F bear the greatest homology and are secreted either as homodimer or heterodimer (23, 24).”
BackgroundCorneth, O. B. J., Mus, A. M. C., Asmawidjaja, P. S., Klein Wolterink, R. G. J., van Nimwegen, M., Brem, M. D., Hofman, Y., Hendriks, R. W., & Lubberts, E. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38229 · Cited by 45
“homodimers or as IL-17A/F heterodimers (18,19).”
BackgroundInterleukin-17 Family Cytokines in Metabolic Disorders and Cancer
Meehan, E. V., & Wang, K. (2022) · Genes · doi:10.3390/genes13091643 · Cited by 51
“Additional proinflammatory cytokines induced by IL-17C include IL-17A/F and IL-22, as well as chemokines CXCL1, CXCL2, CXCL3, and CCL20 [61,64,121].”
BackgroundInfluentialTh17 response in patients with cervical cancer (Review)
Alves, J., Fernandes, T. A. A. D. M., de Ara�jo, J., Cobucci, R. N., Lanza, D. C. F., Bezerra, F., Andrade, V., & Fernandes, J. V. (2018) · Oncology Letters · doi:10.3892/ol.2018.9481 · Cited by 51
“The receptors of IL-17 cytokine are mediators of the biological functions of the IL-17 cytokine family composed of six members ranging from IL-17A to IL‑17F to pro‑inflammatory inducing programs (86), in addition to a heterodimeric species consisting of disulfide‑linked IL-17A and IL-17F (87,88).”
Interleukin-17A and Interleukin-17F: A Tale of Two Cytokines
Dubin, P. J., & Kolls, J. K. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.010 · Cited by 44
“The latter issue is important because it has been shown that IL-17A and IL-17F can form heterodimers that have intermediate bioactivity in vitro (Wright et al., 2007), and it could have been possible that the absence of IL-17F could lead to increased IL-17A homodimer formation (which could have…”
BackgroundSerum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients
Cao, T. B. T., Quoc, Q. L., Choi, Y., Yang, E., Trinh, H. K. T., Shin, Y. S., & Park, H. (2022) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2022.14.1.40 · Cited by 43
Anti-IL-17 phase II data for psoriasis: A review
Brown, G. E., Malakouti, M., Wang, E., Koo, J. Y. M., & Levin, E. C. (2014) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.878448 · Cited by 45
Zhang, Z., Li, Y., Wang, S., Hao, L., Zhu, Y., Li, H., Song, X., Duan, Y., Sang, Y., Wu, P., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01433 · Cited by 40
“IL-17 is expressed by Th17 cells, which are a subset of CD4+ cells (Wright et al., 2007).”
BackgroundIshida, W., Fukuda, K., Higuchi, T., Kajisako, M., Sakamoto, S., & Fukushima, A. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6115 · Cited by 42
IL-17 Signaling-Independent Central Nervous System Autoimmunity Is Negatively Regulated by TGF-β
González-García, I., Zhao, Y., Ju, S., Gu, Q., Liu, L., Kolls, J. K., & Lu, B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802221 · Cited by 42
“Recently, an IL-17–IL-17F heterodimer was found to be expressed in Th17 cells together with IL-17 and IL-17F homodimers (21, 22).”
BackgroundGras, R., Almonacid, L., Ortega, P., Serramía, M. J., Gómez, R., de la Mata, F. J., López-Fernández, L. A., & Muñoz‐Fernández, M. Á. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9776-z · Cited by 42
“IL17 and IL17F form biologically active heterodimers with intermediate potency in inducing inflammatory genes (26,27).”
BackgroundEmerging mediators of airway smooth muscle dysfunction in asthma
Yeganeh, B., Xia, C., Movassagh, H., Koziol‐White, C. J., Chang, Y., Al-Alwan, L. A., Bourke, J. E., & Oliver, B. G. G. (2012) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2012.06.011 · Cited by 41
Update on the role of Interleukin 17 in rheumatologic autoimmune diseases
Konya, C., Paz, Z., Apostolidis, S. A., & Tsokos, G. C. (2015) · Cytokine · doi:10.1016/j.cyto.2015.01.003 · Cited by 35
Iboshi, Y., Nakamura, K., Fukaura, K., Iwasa, T., Ogino, H., Sumida, Y., Ihara, E., Akiho, H., Harada, N., & Nakamuta, M. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1221-1 · Cited by 39
The human IL ‐17A/F heterodimer regulates psoriasis‐associated genes through IκBζ
Bertelsen, T., Iversen, L., & Johansen, C. (2018) · Experimental Dermatology · doi:10.1111/exd.13722 · Cited by 36
A Role for the Cytoplasmic Adaptor Protein Act1 in Mediating IL-17 Signaling
Lindén, A. (2007) · Science's STKE · doi:10.1126/stke.3982007re4 · Cited by 35
Therapeutic potential of targeting IL-17 and its receptor signaling in neuroinflammation
Gautam, A. S., & Singh, R. K. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103517 · Cited by 36
Pappu, B. P., Angkasekwinai, P., & Dong, C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.003 · Cited by 38
“We, as well as others, have shown that IL-17 and IL-17F form biologically active heterodimers with intermediate potency in inducing inflammatory genes (Chang & Dong, 2007; Wright et al., 2007).”
BackgroundDeForge, L. E., Loyet, K. M., Delarosa, D., Chinn, J., Zamanian, F., Chuntharapai, A., Lee, J., Hass, P., Wei, N., Townsend, M. J., et al. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.09.004 · Cited by 38
Espada, A., Broughton, H. B., Jones, S. B., Chalmers, M. J., & Dodge, J. A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01693 · Cited by 34
Regulatory T Cells and IL-17-Producing Cells in Graft-Versus-Host Disease
Teshima, T., Maeda, Y., & Ozaki, K. (2011) · Immunotherapy · doi:10.2217/imt.11.51 · Cited by 36
Zhang, Z., Song, X., Zhang, Z., Li, H., Duan, Y., Zhang, H., Lu, H., Luo, C., & Wang, M. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104750 · Cited by 31
What’s new in asthma pathophysiology and immunopathology?
Orihara, K., Dil, N., Anaparti, V., & Moqbel, R. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.57 · Cited by 39
Tanigawa, S., Aida, Y., Kawato, T., Honda, K., Nakayama, G., Motohashi, M., Suzuki, N., Ochiai, K., Matsumura, H., & Maeno, M. (2011) · Cytokine · doi:10.1016/j.cyto.2011.08.015 · Cited by 33
Shimada, K., Porritt, R. A., Markman, J. L., O’Rourke, J. G., Wakita, D., Rivas, M. N., Ogawa, C., Kozhaya, L., Martins, G. A., Unutmaz, D., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.022 · Cited by 33
Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases
Yan, J.-W., Wang, Y., Peng, W., Tao, J., Wan, Y.-N., Li, B., Mei, B., Chen, B., Yao, H. C., Yang, G., et al. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.843669 · Cited by 30
“IL17F shows a 50% sequence homology and shares the highest amino acid identity with IL-17A, and they can form either disulfide-linked homodimers or heterodimers (IL-17AF) [15].”
BackgroundInfluentialRNA plasticity and selectivity applicable to therapeutics and novel biosensor development
Nakamura, Y., Ishiguro, A., & Miyakawa, S. (2012) · Genes to Cells · doi:10.1111/j.1365-2443.2012.01596.x · Cited by 31
“It has been reported that differentiated Th17 cells form IL-17A ⁄ F heterodimers in higher amounts than they do either homodimer, and distinct from IL-17F ⁄ F, IL-17A ⁄A and IL-17A ⁄ F play primary roles in regulating airway inflammation (Liang et al. 2007; Wright et al. 2007).”
BackgroundCD 4+ T‐cell subsets and host defense in the lung
Kolls, J. K. (2013) · Immunological Reviews · doi:10.1111/imr.12030 · Cited by 37
“As IL-17A and IL-17F can be coexpressed in the same cell, it has been reported that these two IL-17 family members can form three cytokines including IL-17A homodimers, IL-17A/F heterodimers, which have intermediate activity compared with IL17A homodimers, and IL-17F homodimers, which have the least potent activity (8…”
BackgroundMizunoe, S., Shuto, T., Suzuki, S., Matsumoto, C., Watanabe, K., Ueno-Shuto, K., Suico, M. A., Onuki, K., Gruenert, D. C., & Kai, H. (2012) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11240fp · Cited by 27
Gammaherpesvirus Usurps Host IL-17 Signaling To Support the Establishment of Chronic Infection
Jondle, C. N., Johnson, K. E., Aurubin, C. A., Sylvester, P. A., Xin, G., Cui, W., Huppler, A. R., & Tarakanova, V. L. (2021) · mBio · doi:10.1128/mbio.00566-21 · Cited by 24
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
Tam, J. H. K., Robinson, P. C., & Nash, P. T. (2022) · Current Rheumatology Reports · doi:10.1007/s11926-022-01084-4 · Cited by 28
IL-17F/IL-17R interaction stimulates granulopoiesis in mice
Tan, W., Huang, W., Gu, X., Zhong, Q., Liu, B., & Schwarzenberger, P. O. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.06.003 · Cited by 25
The IL-17 pathway as a target in giant cell arteritis
Zeisbrich, M., Thiel, J., & Venhoff, N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199059 · Cited by 29
Could the inhibition of IL-17 or IL-18 be a potential therapeutic opportunity for gastric cancer?
Nguyen, P. M., & Putoczki, T. L. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.008 · Cited by 28
Nesmond, S., Muller, C. B., Naour, R. L., Viguier, M. A., Bernard, P., Antonicelli, F. D., & Jan, S. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02107 · Cited by 26
“IL-17RA pairs with IL-17RC to bind either IL-17A or IL-17F as covalent homodimers, but also IL-17A/IL17F as heterodimers (32, 33).”
BackgroundNovel therapeutic targets along the Th17 pathway
Ouyang, W., Filvaroff, E. H., Hu, Y., & Grogan, J. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200839105 · Cited by 27
Antagonistic RNA aptamer specific to a heterodimeric form of human interleukin-17A/F
Adachi, H., Ishiguro, A., Hamada, M., Sakota, E., Asai, K., & Nakamura, Y. (2011) · Biochimie · doi:10.1016/j.biochi.2011.04.003 · Cited by 25
Altieri, A., Piyadasa, H., Hemshekhar, M., Osawa, N., Recksiedler, B., Spicer, V., Hiemstra, P. S., Halayko, A. J., & Mookherjee, N. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00323-w · Cited by 24
“IL-17A, IL-17F, and IL-17A/F have been demonstrated to induce qualitatively similar gene activation however these are quantitatively different [15].”
BackgroundHo, A. W., Garg, A. V., Monin, L., Simpson-Abelson, M. R., Kinner, L. B., & Gaffen, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070168 · Cited by 26
“Th17 cells also produce IL-17F, a closely related member of the IL-17 cytokine family, a heterodimer of IL-17A/F, and IL-22 [3,4,5].”
BackgroundIL-17 in chronic obstructive pulmonary disease
Cazzola, M., & Matera, M. G. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.7 · Cited by 23
Deknuydt, F., Scotet, E., & Bonneville, M. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.08.003 · Cited by 25
A New Model of Chronic Hapten‐induced Colitis in Young Rats
Fitzpatrick, L. R., Meirelles, K., Small, J. S., Puleo, F. J., Koltun, W. A., & Cooney, R. N. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181cb8f4a · Cited by 30
“IL-17 can exist as both a homodimer and a heterodimer during inflammation (17,18).”
BackgroundMorrison, P. J., Ballantyne, S. J., Macdonald, S. J., Moore, J. W. J., Jenkins, D., Wright, J. F., Fouser, L. A., & Kullberg, M. C. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.08.015 · Cited by 24
IL‐17A and IL‐17F single nucleotide polymorphisms associated with lung cancer in Chinese population
He, Y., Du, Y., Sun, W., Shi, J., Mei, Z., Qian, L., Chen, Z., & Jie, Z. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12330 · Cited by 27
Cytokine crowdsourcing: multicellular production of TH17-associated cytokines
Busman‐Sahay, K., Walrath, T., Huber, S., & O’Connor, W. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0814-386r · Cited by 26
“;35 kDa [12], both of which bind to a heterodimeric complex”
Zhang, Z., Li, Y., Li, H., Song, X., Ma, Z., Lu, H., Liu, S., Zhao, Y. D., Tan, M., Wang, S., et al. (2020) · Vaccines · doi:10.3390/vaccines8020158 · Cited by 22
Panagiotidis, G., Vásquez‐Pacheco, E., Chu, X., Seeger, W., Agha, E. E., Bellusci, S., & Lingampally, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1609509 · Cited by 25
Th17/Treg immunoregulation and implications in treatment of sulfur mustard gas-induced lung diseases
Iman, M., Rezaei, R., Jamalkandi, S. A., Shariati, P., Kheradmand, F., & Salimian, J. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1389646 · Cited by 25
“Both ixekizumab and secukinumab specifically inhibit IL-17A and IL-17A–IL-17A homodimers, with no significant effects on IL-17F–IL-17F homodimers [144].”
BackgroundInflammatory Factors: Nonobese Pediatric Obstructive Sleep Apnea and Adenotonsillectomy
Huang, Y., Chin, W., Guilleminault, C., Chu, K., Lin, C.-H., & Li, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041028 · Cited by 27
“Upregulated IL-17A and IL-17F expressions are found during inflammation [27,28], And patients with severe allergies, chronic inflammatory diseases, and autoimmune diseases can have high levels of IL-17 [26,27].”
BackgroundOftedal, B. E., Kämpe, O., Meager, A., Ahlgren, K. M., Lobell, A., Husebye, E. S., & Wolff, A. S. B. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02573.x · Cited by 21
Metadata
- Authors
- Wright, J. F., Guo, Y., Quazi, A., Luxenberg, D. P., Bennett, F., Ross, J. F., Qiu, Y., Whitters, M. J., Tomkinson, K. N., Dunussi-Joannopoulos, K., Carreno, B. M., Collins, M., & Wolfman, N. M.
- Affiliations
- Wyeth (US)
- Corresponding author
- Carreno, Beatriz M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 18
- Pages
- 13447-13455
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2091653067
- Cited by
- 319
- References
- 36
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 8 · 2023: 12 · 2022: 11 · 2021: 16 · 2020: 15 · 2019: 14 · 2018: 9 · 2017: 16 · 2016: 17 · 2015: 13 · 2014: 15 · 2013: 21 · 2012: 25
- FWCI
- 12.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4932 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17F, IL-17A, CD4+ T cells, T cell activation, cytokine structure, T cell immunity, autoimmune disease
- MeSH terms
- Animals, Autoimmune Diseases, Cricetulus, Cysteine, Gene Expression Regulation, Cricetinae, Humans, Immunity, Cellular, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Gene Expression, CHO Cells, Dimerization, Interleukin-17, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.